Sartorius Stedim Biotech S.A. (EPA:DIM)

Market Cap	18.96B
Revenue (ttm)	2.78B
Net Income (ttm)	175.10M
Shares Out	97.30M
EPS (ttm)	1.81
PE Ratio	107.72
Forward PE	44.94
Dividend	0.69 (0.35%)
Ex-Dividend Date	Apr 2, 2024

Volume	79,513
Average Volume	75,451
Open	194.50
Previous Close	194.90
Day's Range	189.30 - 194.50
52-Week Range	139.10 - 272.90
Beta	0.78
RSI	42.88
Earnings Date	Apr 16, 2025

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiolog...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 9,901
• Stock Exchange: Euronext Paris
• Ticker Symbol: DIM

Financial Performance

In 2024, Sartorius Stedim Biotech's revenue was 2.78 billion, an increase of 0.16% compared to the previous year's 2.78 billion. Earnings were 175.10 million, a decrease of -43.57%.